Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomes. [electronic resource]
Producer: 20080407Description: 370-5 p. digitalISSN:- 0004-3591
- Adult
- Aged
- Alemtuzumab
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Arthritis, Rheumatoid -- drug therapy
- Female
- Follow-Up Studies
- Humans
- Infections -- mortality
- Kaplan-Meier Estimate
- Lymphocyte Subsets -- drug effects
- Lymphopenia -- chemically induced
- Male
- Medical Records
- Middle Aged
- Morbidity
- Neoplasms -- mortality
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.